Literature DB >> 19772706

Uterine peristalsis in women with repeated IVF failures: possible therapeutic effect of hyoscine bromide.

Aki Kido1, Kaori Togashi1, Hiroshi Hatayama2, Takahiro Nakayama2, Akira Yamamoto1, Masako Kataoka1, Togas Tulandi3.   

Abstract

BACKGROUND: Uterine peristalsis, which is influenced by hormonal and cholinergic effects, may have a role in successful implantation and continuing pregnancy. CASES: We encountered abnormal uterine peristalsis in three women who had had repeated in vitro fertilization (IVF) treatment failures. They subsequently had successful pregnancies when hyoscine bromide was administered at the time of embryo transfer.
CONCLUSION: It is possible that decreasing uterine peristalsis with use of an anticholinergic agent during IVF treatment facilitates retention of embryos and increases the probability of successful pregnancy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19772706     DOI: 10.1016/S1701-2163(16)34278-5

Source DB:  PubMed          Journal:  J Obstet Gynaecol Can        ISSN: 1701-2163


  4 in total

Review 1.  Uterine anatomy and function on cine magnetic resonance imaging.

Authors:  Aki Kido; Kaori Togashi
Journal:  Reprod Med Biol       Date:  2016-02-13

2.  Evaluation of the effect of oral ritodrine on implantation rate in in-vitro fertilization-embryo transfer cycles.

Authors:  Soghra Rabiee; Marziyyeh Farimani; Maryam Ahmadi
Journal:  Iran J Reprod Med       Date:  2011

3.  A double-blinded, randomized, placebo-controlled trial assessing the effects of nifedipine on embryo transfer: Study protocol.

Authors:  Kelvin Kl Ng; Genia Rozen; Tanya Stewart; Franca Agresta; Alex Polyakov
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

4.  Does nifedipine improve outcomes of embryo transfer?: Interim analysis of a randomized, double blinded, placebo-controlled trial.

Authors:  Kelvin Kwok Lap Ng; Genia Rozen; Tanya Stewart; Franca Agresta; Alex Polyakov
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.